|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
|
Cancer Type: ACC |
Summary for ACC |
 Patient number summary of ACC. |
| Cancer Type | Male Tumor Patients | Female Tumor Patients | Male Normal Patients | Female Normal Patients |
| ACC | 31 | 48 | 0 | 0 |
| Result summary of ACC. |
| Molecular | Sex-biased moleculars | Female-specific DEmoleculars | Male-specific DEmoleculars |
| ASevents | 5 | 1 | - |
| A-to-I editing | 49 | - | - |
| Coding Gene | 179 | 5 | 7 |
| lncRNA | 10 | - | - |
| Methy | 2111 | - | - |
| miRNA | 6 | - | - |
| Protein | 44 | - | - |
| ∗Please click the number for more information. ∗For lncRNA and miRNA, Please click the download page for more detail. |
| Functional enrichment analysis of ACC. |
 | |||||||
| Cancer Type | Term | Genes | Type | ||||
| ACC | Staphylococcus aureus infection | FCGR3A;FCGR2A;KRT17;C5AR1 | Malebaised | ||||
| ACC | Neutrophil extracellular trap formation | FCGR3A;FCGR2A;C5AR1;CASP1 | Malebaised | ||||
| ACC | Coronavirus disease | FCGR2A;C5AR1;CASP1;RPS4Y1 | Malebaised | ||||
| ACC | Osteoclast differentiation | FCGR3A;FCGR2A;TREM2 | Malebaised | ||||
| ACC | Phagosome | COLEC12;FCGR3A;FCGR2A | Malebaised | ||||
| ACC | Legionellosis | CASP1;CXCL1 | Malebaised | ||||
| ACC | NOD-like receptor signaling pathway | AIM2;CASP1;CXCL1 | Malebaised | ||||
| ACC | Cytosolic DNA-sensing pathway | AIM2;CASP1 | Malebaised | ||||
| ACC | Leishmaniasis | FCGR3A;FCGR2A | Malebaised | ||||
| ACC | Complement and coagulation cascades | C5AR1;PLAUR | Malebaised | ||||
| ACC | Fc gamma R-mediated phagocytosis | FCGR3A;FCGR2A | Malebaised | ||||
| ACC | Terpenoid backbone biosynthesis | FDPS;IDI1;MVD;ACAT2 | Femalebaised | ||||
| ACC | Phenylalanine metabolism | AOC3;PAH;HPD | Femalebaised | ||||
| ACC | Pyruvate metabolism | ACSS2;ACAT2;PCK2 | Femalebaised | ||||
| ACC | Steroid biosynthesis | CYP51A1;LSS | Femalebaised | ||||
| ACC | Proximal tubule bicarbonate reclamation | CA4;PCK2 | Femalebaised | ||||
| ACC | Glycolysis / Gluconeogenesis | ACSS2;ALDOB;PCK2 | Femalebaised | ||||
| ACC | PPAR signaling pathway | FABP4;PLIN2;PCK2 | Femalebaised | ||||
| ACC | Citrate cycle (TCA cycle) | ACLY;PCK2 | Femalebaised | ||||
| ACC | Glyoxylate and dicarboxylate metabolism | ACSS2;ACAT2 | Femalebaised | ||||
| ACC | Propanoate metabolism | ACSS2;ACAT2 | Femalebaised | ||||
| ACC | Tyrosine metabolism | AOC3;HPD | Femalebaised | ||||
Top |
Sex-biased mutation in ACC |
| Sex-biased mutation in ACC. |
 |
Top |
TF-Gene regulation in ACC |
| Top20 sex-biased TF-Gene regulation in ACC. |
 |
| Table of top20 male-biased TF-Gene regulation in ACC. |
| Cancer Type | Sex | Gene ID | TF | Gene Symbol | Score |
| ACC | Male | ENSG00000000419 | TEF | DPM1 | 9.96843159356488 |
| ACC | Male | ENSG00000000419 | CENPBD1 | DPM1 | 9.34752696715487 |
| ACC | Male | ENSG00000127249 | CENPBD1 | ATP13A4 | 9.09810393919478 |
| ACC | Male | ENSG00000000419 | DBP | DPM1 | 7.93761409895968 |
| ACC | Male | ENSG00000000419 | HOXC12 | DPM1 | 7.90454782690756 |
| ACC | Male | ENSG00000000419 | HOXD12 | DPM1 | 7.88015440543398 |
| ACC | Male | ENSG00000178690 | ONECUT2 | DYNAP | 7.86405532371738 |
| ACC | Male | ENSG00000088298 | IRX5 | EDEM2 | 7.80821102403616 |
| ACC | Male | ENSG00000088298 | ZBTB32 | EDEM2 | 7.80774300532649 |
| ACC | Male | ENSG00000029559 | POU1F1 | IBSP | 7.71656175542038 |
| ACC | Male | ENSG00000253626 | ZNF45 | EIF5AL1 | 7.68684400758099 |
| ACC | Male | ENSG00000183395 | DMRT2 | PMCH | 7.58766053460366 |
| ACC | Male | ENSG00000125977 | TLX3 | EIF2S2 | 7.55022827520227 |
| ACC | Male | ENSG00000116031 | MESP2 | CD207 | 7.50345379128434 |
| ACC | Male | ENSG00000158497 | HSFY2 | HMHB1 | 7.45760434818656 |
| ACC | Male | ENSG00000184895 | FOXF2 | SRY | 7.40456522523529 |
| ACC | Male | ENSG00000158497 | MEIS1 | HMHB1 | 7.32250476530907 |
| ACC | Male | ENSG00000154007 | IRX5 | ASB17 | 7.19027128480153 |
| ACC | Male | ENSG00000183395 | FOXD2 | PMCH | 7.15732403232683 |
| ACC | Male | ENSG00000029559 | ZFP1 | IBSP | 7.14894640340877 |
| ∗Please click the gene id for more information. |
| Table of top20 female-biased TF-Gene regulation in ACC. |
| Cancer Type | Sex | Gene ID | TF | Gene Symbol | Score |
| ACC | Female | ENSG00000175820 | BCL6B | CCDC168 | 8.31051105507274 |
| ACC | Female | ENSG00000165606 | DMRTC2 | DRGX | 8.13683044660944 |
| ACC | Female | ENSG00000002745 | SOX12 | WNT16 | 8.08994291917552 |
| ACC | Female | ENSG00000248713 | ONECUT3 | C4orf54 | 7.95669441676209 |
| ACC | Female | ENSG00000139675 | LHX8 | HNRNPA1L2 | 7.86846693910232 |
| ACC | Female | ENSG00000248713 | SRF | C4orf54 | 7.83106630254154 |
| ACC | Female | ENSG00000198680 | SOX8 | TUSC1 | 7.76087254623635 |
| ACC | Female | ENSG00000248713 | HMX1 | C4orf54 | 7.75197934954331 |
| ACC | Female | ENSG00000175820 | NANOG | CCDC168 | 7.69700296916636 |
| ACC | Female | ENSG00000117601 | DMRTC2 | SERPINC1 | 7.67911549565579 |
| ACC | Female | ENSG00000175820 | ZNF418 | CCDC168 | 7.61204394271179 |
| ACC | Female | ENSG00000175820 | MEF2A | CCDC168 | 7.60633899588092 |
| ACC | Female | ENSG00000248713 | LMX1B | C4orf54 | 7.45897084672236 |
| ACC | Female | ENSG00000248713 | ZNF620 | C4orf54 | 7.41335326616209 |
| ACC | Female | ENSG00000165606 | OTX2 | DRGX | 7.33987594211763 |
| ACC | Female | ENSG00000198680 | ZNF45 | TUSC1 | 7.21004965617394 |
| ACC | Female | ENSG00000091138 | HOXD11 | SLC26A3 | 7.11747142340418 |
| ACC | Female | ENSG00000180660 | VSX1 | MAB21L1 | 7.11744153576858 |
| ACC | Female | ENSG00000188993 | ZNF653 | LRRC66 | 6.9812270051931 |
| ACC | Female | ENSG00000180660 | PBX4 | MAB21L1 | 6.95298710493775 |
| ∗Please click the gene id for more information. |
Top |
RBP-ES regulation in ACC |
| Top20 sex-biased RBP-ES regulation in ACC. |
 |
| Table of top20 male-biased RBP-ES regulation in ACC. |
| Cancer Type | Sex | Gene ID | RBP | ES | Score |
| ACC | Male | ENSG00000134057 | MSI1 | exon_skip_435219 | 17.4958873546237 |
| ACC | Male | ENSG00000164961 | RBM3 | exon_skip_492343 | 16.5196656451571 |
| ACC | Male | ENSG00000100650 | STAR-PAP | exon_skip_107749 | 16.4126627310052 |
| ACC | Male | ENSG00000124228 | STAR-PAP | exon_skip_352920 | 16.4126627310052 |
| ACC | Male | ENSG00000120705 | STAR-PAP | exon_skip_444574 | 16.4126627310052 |
| ACC | Male | ENSG00000185624 | ANKHD1 | exon_skip_294580 | 15.7823548280394 |
| ACC | Male | ENSG00000072506 | ANKHD1 | exon_skip_515081 | 15.7595758702618 |
| ACC | Male | ENSG00000169223 | ANKHD1 | exon_skip_446533 | 15.7479510126923 |
| ACC | Male | ENSG00000130520 | ANKHD1 | exon_skip_316424 | 15.7302513540174 |
| ACC | Male | ENSG00000144591 | DAZAP1 | exon_skip_334067 | 15.4300169154662 |
| ACC | Male | ENSG00000106070 | DAZAP1 | exon_skip_475565 | 15.4300169154662 |
| ACC | Male | ENSG00000196510 | DAZAP1 | exon_skip_96217 | 15.4300169154662 |
| ACC | Male | ENSG00000185246 | QKI | exon_skip_106324 | 15.3818440960694 |
| ACC | Male | ENSG00000162441 | QKI | exon_skip_21707 | 15.3818440960694 |
| ACC | Male | ENSG00000120137 | QKI | exon_skip_446112 | 15.3818440960694 |
| ACC | Male | ENSG00000120451 | QKI | exon_skip_78662 | 15.3818440960694 |
| ACC | Male | ENSG00000061794 | QKI | exon_skip_80932 | 15.3818440960694 |
| ACC | Male | ENSG00000111142 | QKI | exon_skip_85934 | 15.3818440960694 |
| ACC | Male | ENSG00000120438 | QKI | exon_skip_463216 | 15.3818440960693 |
| ACC | Male | ENSG00000090273 | ZNF638 | exon_skip_3041 | 15.1111432159489 |
| ∗Please click the gene id for more information. |
| Table of top20 female-biased RBP-ES regulation in ACC. |
| Cancer Type | Sex | Gene ID | RBP | ES | Score |
| ACC | Female | ENSG00000175221 | ANKHD1 | exon_skip_312392 | 15.79772219373 |
| ACC | Female | ENSG00000143153 | MSI1 | exon_skip_13932 | 15.564281156588 |
| ACC | Female | ENSG00000122545 | DAZAP1 | exon_skip_465385 | 15.4273186281812 |
| ACC | Female | ENSG00000152942 | QKI | exon_skip_435311 | 15.3800220213946 |
| ACC | Female | ENSG00000038358 | ZNF638 | exon_skip_137869 | 15.113383093722 |
| ACC | Female | ENSG00000175029 | ZNF638 | exon_skip_54642 | 15.113383093722 |
| ACC | Female | ENSG00000115241 | RBM3 | exon_skip_337893 | 14.554701786357 |
| ACC | Female | ENSG00000100650 | STAR-PAP | exon_skip_107751 | 14.5488730481047 |
| ACC | Female | ENSG00000166033 | RBMS1 | exon_skip_45676 | 14.3800473943802 |
| ACC | Female | ENSG00000167522 | RBM8A | exon_skip_147019 | 14.2363888338553 |
| ACC | Female | ENSG00000138078 | MSI1 | exon_skip_338767 | 14.156855666026 |
| ACC | Female | ENSG00000106400 | MSI1 | exon_skip_470000 | 13.9373570127863 |
| ACC | Female | ENSG00000057608 | MSI1 | exon_skip_47516 | 13.7112523355801 |
| ACC | Female | ENSG00000155975 | RBM42 | exon_skip_481408 | 13.5533786820377 |
| ACC | Female | ENSG00000052126 | RBM42 | exon_skip_80560 | 13.5533786820377 |
| ACC | Female | ENSG00000057608 | ANKHD1 | exon_skip_47516 | 13.5465364803596 |
| ACC | Female | ENSG00000142507 | DAZAP1 | exon_skip_148063 | 13.5200550957876 |
| ACC | Female | ENSG00000079950 | QKI | exon_skip_462370 | 13.5086033323497 |
| ACC | Female | ENSG00000126067 | STAR-PAP | exon_skip_24920 | 13.4834930609607 |
| ACC | Female | ENSG00000134759 | SFPQ | exon_skip_296500 | 13.4726839969655 |
| ∗Please click the gene id for more information. |
Top |
eQTL regulation in ACC |
 |
| Top Male-specific cis-sQTM regulation (FDR <1e-5). |
| Cancer Type | Gene ID | Gene Name | SNP ID |
| ∗Please click the gene id for more information. |
 |
| Female-specific cis-eQTL regulation (FDR <1e-5). |
| Cancer Type | Gene ID | Gene Name | SNP ID |
| ∗Please click the gene id for more information. |
 |
| Opposite sex-biased cis-eQTL regulation (FDR <1e-5). |
| Cancer Type | Gene ID | Gene Name | SNP ID |
| ∗Please click the gene id for more information. |
Top |
sQTL regulation in ACC |
|
| Male-specific cis-sQTL regulation (FDR <1e-5). |
| Cancer Type | Gene ID | Gene Name | ES ID | SNP ID |
| ∗Please click the gene id for more information. |
|
| Female-specific cis-sQTL regulation (FDR <1e-5). |
| Cancer Type | Gene ID | Gene Name | ES ID | SNP ID |
| ∗Please click the gene id for more information. |
|
| Opposite sex-biased cis-sQTL regulation (FDR <1e-5). |
| Cancer Type | Gene ID | Gene Name | ES ID | SNP ID |
| ∗Please click the gene id for more information. |
Top |
eQTM regulation in ACC |
|
| Male-specific cis-eQTM regulation (FDR <1e-5). |
| Cancer Type | Gene ID | CpG ID |
| ∗Please click the gene id for more information. |
|
| Female-specific cis-eQTM regulation (FDR <1e-5). |
| Cancer Type | Gene ID | CpG ID |
| ∗Please click the gene id for more information. |
|
| Opposite sex-biased cis-eQTM regulation (FDR <1e-5). |
| Cancer Type | Gene ID | CpG ID |
| ∗Please click the gene id for more information. |
Top |
sQTM regulation in ACC |
|
| Male-specific cis-sQTM regulation (FDR <1e-5). |
| Cancer Type | Gene ID | Gene Name | ES ID | CpG ID |
| ∗Please click the gene id for more information. |
|
| Female-specific cis-sQTM regulation (FDR <1e-5). |
| Cancer Type | Gene ID | Gene Name | ES ID | CpG ID |
| ∗Please click the gene id for more information. |
|
| Opposite sex-biased cis-sQTM regulation (FDR <1e-5). |
| Cancer Type | Gene ID | Gene Name | ES ID | CpG ID |
| ∗Please click the gene id for more information. |
